18 and older, any sex, with Smoking or Pain. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Who Abstained From Smoking Cigarettes at 6months (Prolonged Abstinence)Primary· 6-month
In the past 6 months, have he/she smoked any in each of 2 consecutive weeks?
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
43
Smoking Cessation Standard (SMK-STD)
41
Number of Participants Who Abstained From Smoking Cigarettes at 12 Months (Prolonged Abstinence)Primary· 12-month post intervention
In the past 6 months, have he/she smoked any in each of 2 consecutive weeks?
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
40
Smoking Cessation Standard (SMK-STD)
38
Number of Participants Who Abstained From Smoking Part of a Cigarette at 6months (30-day Point Prevalence)Primary· 6-month post intervention
30-day point prevalence abstinence rates, Have he/she smoked at least part of a cigarette in last 30 days?
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
23
Smoking Cessation Standard (SMK-STD)
11
Number of Participants Who Abstained From Smoking Part of a Cigarette at 12 Months (30-day Point Prevalence)Primary· 12 month post intervention
30-day point prevalence abstinence rates, have he/she smoked at least part of a cigarette in last 30 days?
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
25
Smoking Cessation Standard (SMK-STD)
18
Change in Brief Pain Inventory (BPI) Pain Intensity, Difference From Baseline to Follow-up at 6 MonthsSecondary· Baseline to 6-month post intervention
BPI Pain Intensity takes the mean of 4 self-reported numeric rating scale questions about one's pain: worst, least, current, and average pain. Rate pain on a 0 (no pain) to 10 (worst pain imaginable) scale. Veterans will be asked at baseline and after intervention. We are showing the change from baseline to follow-up, a negative score means the pain intensity has decreased.
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
-0.7
± 1.7
Smoking Cessation Standard (SMK-STD)
-0.5
± 1.8
Change in Pain Interference, Difference Between Baseline and Follow-up at 6 MonthsSecondary· Baseline to 6-month post intervention
Pain interference will be measured by the Brief Pain Inventory (BPI). Veterans will be asked at baseline and after intervention. How does pain interfere on a 0 (no interference) to 10 (completely interferes) scale on 7 different facets of living. The total is the mean of all 7 questions. Veterans will be asked at baseline and after intervention. We are showing the change from baseline to follow-up, a negative score means the pain interference has decreased.
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
-0.72
± 2.4
Smoking Cessation Standard (SMK-STD)
-0.36
± 2.2
Change in Brief Pain Inventory (BPI) Pain Intensity, Difference in Pain Intensity Between Baseline and 12 MonthsSecondary· Baseline to 12-month post-intervention
BPI Pain Intensity takes the mean of 4 self-reported numeric rating scale questions about one's pain: worst, least, current, and average pain. Rate pain on a 0 (no pain) to 10 (worst pain imaginable) scale. Veterans will be asked at baseline and after intervention. We are showing the change from baseline to follow-up, a negative score means the pain intensity has decreased.
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
-.044
± 1.6
Smoking Cessation Standard (SMK-STD)
-0.35
± 1.7
Change in Pain Interference, Difference Between Baseline and InterferenceSecondary· Baseline to 12-month post intervention
Pain interference will be measured by the Brief Pain Inventory (BPI). Veterans will be asked at baseline and after intervention. How does pain interfere on a 0 (no interference) to 10 (completely interferes) scale on 7 different facets of living. The total is the mean of all 7 questions. Veterans will be asked at baseline and after intervention. We are showing the change from baseline to follow-up, a negative score means the pain interference has decreased
Group
Value
95% CI
Smoking Cessation Plus CBI (SMK-CBI)
-.56
± 2.3
Smoking Cessation Standard (SMK-STD)
-.46
± 2.1
Sponsor's own description
This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction
· NA
· recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
· NA
· recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products
· NA
· recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health
· NA
· recruiting
NCT06713603 — Technology Assisted Motivational Interviewing
· NA
· recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
· Phase 1
· not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran
· NA
· not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness
· NA
· not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
· NA
· not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 28 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02971137.